Vapes Outperform Nicotine Replacement Therapy in Cessation Trial
-
By
July 17, 2025
-
3 min
-
1
VNPs may be more effective than NRT for smoking cessation.
-
2
Study enrolled 1,045 participants from disadvantaged backgrounds.
-
3
28.4% of VNP users achieved verified abstinence at 7 months.
-
4
9.6% of NRT users achieved the same outcome.
-
5
Better treatment adherence was noted in the VNP group.
-
6
Fewer adverse events reported in the VNP group compared to NRT.
-
7
The study indicates the effectiveness of VNPs in socioeconomically disadvantaged populations.
-
A clinical trial demonstrated that adults from socioeconomically disadvantaged backgrounds were nearly three times more successful in quitting smoking with vaporized nicotine products (VNPs) compared to nicotine replacement therapy (NRT). Conducted in New South Wales, Australia, the study enrolled 1,045 daily smokers receiving government support and showed that 28.4% of VNP users achieved verified abstinence at a 7-month follow-up, compared to 9.6% in the NRT group. VNPs exhibited better adherence and fewer adverse events, indicating their potential as a preferred option for smoking cessation in these populations.
-
1
VNPs may be more effective than NRT for smoking cessation.
-
2
Study enrolled 1,045 participants from disadvantaged backgrounds.
-
3
28.4% of VNP users achieved verified abstinence at 7 months.
-
4
9.6% of NRT users achieved the same outcome.
-
5
Better treatment adherence was noted in the VNP group.
-
6
Fewer adverse events reported in the VNP group compared to NRT.
-
7
The study indicates the effectiveness of VNPs in socioeconomically disadvantaged populations.
Listen Tab content
